Rebalix
Logo AmundiAmundi · sheet of 5 September 2026
ETF sheet · official issuer and register data

Amundi Core MSCI Europe UCITS ETF Dist

10AI · LU1737652310 · class UCITS ETF Dist · EUR · domicile Luxembourg
Equity · EuropeSFDR art. 6
Index tracked: MSCI Europe Net Return EUR Index
TER
0.12%+ trans. 0.08%
Fund size
458 m EUR
Tracking difference
+0.23%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingannual
Launch 19 Dec 2017 · costs from the KID as of 2 Sept 2026 · 411 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the index constituents are included in the Index return. MSCI Europe Index is an equity index representative of the large…

Performance since series start (in euro) — base 100

17 Jan 20183 Sept 2026 · dividends reinvested where declared by the issuer
201920212023202521078207
High 210 (10 Aug 2026) · low 78 (17 Mar 2020) · last 207. Past performance is not indicative of future results.

Returns in euro

1 year+22.8%
3 years+53.2%
5 years+59.6%
10 yearsseries too young
Since series start+107.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.39%12.57%14.08%
Max drawdown−9.39%−16.27%−19.86%
Sharpe1.260.720.37
Sortino1.900.980.51
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · 10AI · LU17376523101
Rebalix10AI · LU1737652310 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+19.67%+19.39%+0.28%
2024+8.79%+8.59%+0.20%
2023+16.06%+15.83%+0.22%
2022−9.25%−9.49%+0.25%
2021+25.41%+25.13%+0.28%

Distributions · per share, in EUR

Frequency: annual · last 12 months: 1.87 EUR (2.24% of NAV) · last ex-date 9 Dec 2025
YearPaymentsTotal (EUR)Dividend yield
202511.87+2.93%
202411.79+2.97%
202311.67+3.13%
202211.62+2.68%
202111.32+2.68%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 27 Aug 2026 · 411 securities · top-10 weight = 20.8%
Top holdingsWeight
ASML HOLDING NV4.6%
HSBC HOLDINGS PLC2.4%
ROCHE HOLDING AG - GENUSSS CHF2.2%
NOVARTIS AG-REG1.9%
SHELL PLC GBP1.7%
NESTLE SA-REG1.7%
ASTRAZENECA GBP1.7%
SIEMENS AG-REG1.7%
SAP SE / XETRA1.6%
BANCO SANTANDER SA MADRID1.4%
Countries (% of fund)
United Kingdom22.3%France14.9%Switzerland14.4%Germany14.0%Netherlands8.9%
Sectors (% of fund)
Financials25.5%Industrials19.1%Health Care12.9%Information Technology9.1%Consumer Staples8.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
10AI · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU1737652310/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU1737652310/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU1737652310/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU1737652310
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · 10AI · LU17376523102